Capbio: Announcement on share repurchase results and share changes
Capbio: Announcement on the wholly-owned subsidiary obtaining the “Drug Clinical Trial Approval Notice”
CapBio: Guangdong Cape Biotech Co., Ltd. Investor Relations Activity Record Form (2024 Investor Online Group Reception Day Event in Guangdong Province)
Capbiotech: Announcement on the acquisition of medical device registration certificates by wholly-owned subsidiaries
CapBio: Announcement on participating in the 2024 Investor Online Group Reception Day in Guangdong
CapBio: Announcement on the progress of repurchasing the company\'s shares through centralized bidding transactions for the second time in 2024
Capbio: Announcement on the Company and Its Subsidiaries Obtaining Patent Authorization
Capbio: Investor Relations Activity Record Form for August 29, 2024
CapBio: CITIC Securities Co., Ltd.\'s verification opinion on the company\'s use of temporarily idle funds raised for cash management
Capbio: Special Report on the Storage and Use of Funds Raised for the Semi-Annual Year 2024
Capbiotech: Announcement on the Use of Temporarily Idle Raised Funds for Cash Management
CapBio: Announcement on preparations for asset impairment for the semi-annual calculation of 2024
Capbio: 2024 Semi-Annual Report
Capbio: Summary table of non-operating capital expenditure and other related capital transactions for the 2024 semi-year
CapBio: Prompt Announcement on the Disclosure of the 2024 Semi-Annual Report
Capbio: Announcement of Board of Supervisory Committee Resolutions
Capbio: 2024 Semi-Annual Report Summary
Capbio: Announcement of Board Resolutions
Guangdong Hybribio Biotech: Stock trading has experienced abnormal fluctuations announcement.
Guangdong Hybribio Biotech: Announcement Regarding the Progress of the Second Repurchase of Company Shares through Centralized Auction Trading Method in 2024
No Data
No Data